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Endometriosis is defined as the presence of endometrial glands and stroma outside the uterus. It affects 3 to 10 percent of women
of reproductive age. Umbilical endometriosis is rare, with an estimated incidence of 0.5–1.0% among all cases of endometriosis,
and is usually secondary to prior laparoscopic surgery involving the umbilicus. In this report, we described a case of umbilical
endometriosis treated with surgical resection and highlight the great importance of medical history compared to complementary
diagnostic tests that can be sometimes inconclusive.
1. Introduction
Endometriosis is a common benign disease, which is defined
by the presence of endometrial tissue outside the uterus
[1]. The first description of this condition was made by a
German physician, Daniel Schroen, in 1690 [2]. It affects
3 to 10 percent of women of reproductive age [3, 4] and
represents an important cause of infertility [5]. It occurs
in 2–22% of asymptomatic patients, in 20–30% of infertil-
ity cases, and in 40–60% of dysmenorrhoea cases [6]. Its
etiopathogenesis is not well established yet. Endometriosis
can affect any woman from premenarche [7] until post-
menopause, irrespective of the race, ethnicity, or maternal
status [8, 9]. It is reported that up to 70% of adolescents
with chronic pelvic pain before menarche can be affected
with endometriosis [7]. The most frequent locations include
the ovaries, the uterosacral ligaments, the pouch of Douglas,
and the other pelvic organs. Extraperitoneal locations as
cervix, vagina, vulva, lungs, umbilicus, or postoperative scars
are uncommon [6] and locations like nasal mucosa, brain,
and eyes are very rare [10]. There is little evidence on the
real incidence and prevalence of these extrapelvic lesions.
Umbilical endometriosis rarely occurs, with an estimated
incidence of 0.5–1.0% among all cases of endometriosis [11,
12], usually affecting patients after laparoscopy or other sur-
gical procedures involving the umbilicus [4] (of the reported
cases of cutaneous endometriosis, over 70% are secondary to
prior surgery and occur at the site of surgical scars) [13, 14].
Umbilical endometriosis can be classified as primary, named
Villar’s nodule, when it appears spontaneously (any ectopic
endometrium that is found superficial to the peritoneum
without any history of previous surgery) or secondary, when
it appears after surgical procedures. The term secondary
endometriosis can be used even when it is not located on
surgical scars, such as on the umbilicus, but only if its
onset occurs within 2 years after the procedure [15–17]. The
differential diagnosis of umbilical tumors inwomen comprise
endometriosis in 32.2%, benign primary tumor in 29.7%,
metastatic tumor in 29.7%, and malignant primary tumor
in 8.4% [12, 18]. The maximal depth of penetration of the
umbilical endometriosis described is up to the fascial level
[19–21].
To treat umbilical endometriosis, wide resection with
2mm margins is generally recommended [22] and there are
few cases in which conservative treatment is indicated [23].
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Figure 1: Umbilical nodule bleeding during menstrual cycle.
The authors report a case of a patient with umbilical
endometriosis associated with a previous laparoscopic inter-
vention and treated by surgical excision.
2. Case Presentation
A forty-two-year-old healthy female, with menarche at the
age of 13, was referred to the gynecology department by
general surgery, with a livid coloured nodule in the umbilicus
which gradually increased in size over the past 3 years. She
also presented with dysmenorrhoea (numeric rating scale of
pain (NRS): 10), dyspareunia (NRS: 10), dyschezia (NRS: 7),
and tenesmus. She was medicated with an oral contraceptive
with ethinylestradiol and gestodene.The nodule was painless
and the patient mentioned cyclical umbilical bleeding syn-
chronized with menstruation (Figure 1), during withdrawal
bleeding. She had irregular menstruation periods and a
cesarean for fetal breech presentation 9 years before. The
patient had past history of laparoscopic appendectomy five
years previously, with umbilical cannulation.The histopatho-
logical examination of the appendix revealed endometriosis.
She has no known family history of endometriosis. At
physical examination, she had a soft swelling nodule, with two
bluish-purple dots, in the umbilicuswith a diameter of 1.2 cm,
with a normal skin envelope, that was irreductible (Fig-
ure 2). In this first gynecological consultation, the hormonal
medication was changed to dienogest 2mg continuously.
The patient stayed in amenorrhea with no bleeding of the
umbilical nodule.
Abdominal examination was otherwise normal with no
clinical signs of hernia. The first ultrasonography of the
umbilical nodule revealed an image suggestive of dermoid
cyst. Pelvic computed tomography (CT) scan revealed two
contiguous cystic images with peripheral contrast enhance-
ment in the left adnexal area that were included in the differ-
ential diagnosis of endometrioma, tubo-ovarian abscess, and
serous cystadenoma. A second ultrasound scan of the lesion
revealed two superficial cysts measuring 2mm and another
deeper cystmeasuring 4mm,with nonspecific aspect, though
compatible with sebaceous or dermal inclusion cysts. Mag-
netic resonance imaging (MRI) showed uterus measuring 92
× 40 × 58mm, with multiple small nodules showing signal
hypointensity on T2-weighted imaging regarded as intramu-
ral leiomyomas and the presence of some endometrial glands
suggesting adenomyosis, endometriumwith 6mm(Figure 3).
MRI also revealed a left septated ovarian cyst measuring
Figure 2: Umbilical nodule.
40 × 33mm and a second cyst of 28 × 18 × 24mm, containing
fluid showing signal hyperintensity on T1-weighted imaging
and slightly signal hyperintensity on T2-weighted imaging,
suggesting hemorrhagic cyst or endometrioma (Figure 4).
The patient underwent excision of the nodule under
general anesthesia. The nodule was supra-aponeurotic with
central extension (hernial ring) to the abdominal peritoneum
(Figure 5). Diagnostic laparoscopy was also performed and
intraoperative findings showed several typical endometrio-
sis spots in the vesicouterine fold, pelvic peritoneum, and
posterior fornix, increased right ovary measuring 3 cm with
a simple cyst of 2.5 cm, and an endometrioma measuring
less than 1 cm. Cauterization of endometriotic lesions with
bipolar energy and spontaneous drainage and coagulation of
the capsule of the endometrioma were performed. She was
discharged from hospital after 24 hours and medicated with
desogestrel on a continuous basis.
The patient was observed at 1, 3, 6, and 12 months after
surgery and there was no evidence of clinical recurrence
13 months after that. The hormonal medication was then
changed to dienogest plus ethinylestradiol and the patient
remained asymptomatic. Histology of the lesion showed
the presence of endometrial glands and stroma; therefore a
diagnosis of umbilical endometriosis was made. The clinical
evaluation for follow-up will be done annually.
3. Discussion
Endometriosis is a common disorder, defined as the
extrauterine presence of endometrial glands and stroma.
It is a common, estrogen-dependent inflammatory disease,
affecting 3–10% of women in the reproductive age [24, 25].
Endometriosis is mostly located in the pelvis but can also be
encountered at nearly any organ of the body, as the lungs,
bowel, ureter, brain, inguinal canal, and abdominal wall
[3, 26–28]. The symptoms most frequently associated with
endometriosis are pelvic pain, dysmenorrhoea, dyspareunia,
and subfertility/infertility [24, 25, 29]. Its pathogenesis is not
completely understood and multiple theories have been pro-
posed to explain it: implantation of endometrial cells through
retrograde menstruation (endometrial tissue is transported
during menstruations from the uterus through the fallopian
tubes, therefore gaining access to and implanting on pelvic
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(a) (b)
Figure 3: MRI: T2-weighted imaging. (a) Coronal view. (b) Axial view: uterus with multiple small nodules regarded as leiomyomas and with
some endometrial glands suggesting adenomyosis.
(a) (b)
Figure 4: MRI: T2-weighted imaging. (a) Sagittal view. (b) Coronal view: left ovarian cyst.
Figure 5: Umbilical nodule resected.
structures (the implantation or retrograde menstruation
theory) [3]), haematogenous or lymphatic dissemination
of endometrial cells (the dissemination theory), ectopic
differentiation of pluripotent peritoneal progenitor cells to
endometrial tissue (coelomic metaplasia theory) [3, 24, 25,
30], production of substances to form endometriosis by
sloughed endometrium (the induction theory), specific stim-
ulation to aMu¨llerian origin cell nest producing endometrio-
sis (the embryonic rest theory), and proliferation of ectopic
endometrial cells produced by alterations in cell-mediated
and humoral immunity (the cellular immunity theory) [3].
The most common locations of endometriosis are the
ovaries (up to 88% of all cases), followed by the appendix,
intestine, cervix, omentum, and skin [2]. In 70% of cuta-
neous endometriosis, it is more frequently secondary, follow-
ing abdominopelvic surgery, but can appear spontaneously
(30%), when in the absence of prior surgery [2]. In the latter
case, it appears most commonly on the umbilicus, followed
by the inguinal region [2, 11, 12], and there are cases in which
the lateral abdominal wall is involved [3, 31, 32].
The pathogenesis of primary umbilical endometriosis is
still unclear. Possible explanations for this disorder could
be the migration of endometrial cells to the umbilicus
through the abdominal cavity, the lymphatic system, or
through the embryonic remnants in the umbilical fold such
as the urachus and the umbilical vessels [12, 18], genetic
predisposition, and immunological defects [6]. The most
feasible explanation for secondary umbilical endometriosis
is the direct transplantation theory which says that this type
of endometriosis is caused by iatrogenic dissemination of
endometrial cells, for example, a laparoscopic operation [3].
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Spontaneous cutaneous endometriosis is associated with
more severe pelvic disease than scar endometriosis [12, 20].
Extragenital or extrapelvic endometriosis is even more
difficult to diagnose due to the extreme variability in presen-
tation [33]. Umbilical endometriosis presents as a rubbery or
firm nodule, and the size can vary from several millimeters
to 6 cm. A pathognomonic sign for this type of lesion is the
umbilical sanguinolent discharges simultaneously with the
menstruation period [6]. Clinical symptoms typically include
pain, bleeding, and swelling concurrently withmenstruation,
but some patients are asymptomatic [2, 12]. Nevertheless,
there are studies which describe the pain as constantly
present and with no association with the menstrual cycle in
most cases [3, 34]. The presence of concomitant abdominal
masses or previous history of endometriosis is common
(26% of cases) [24], frequently associated with complaints of
dysmenorrhoea, dyspareunia, or defecation pain [2].
Numerous studies have reported a long delay in the
diagnosis of endometriosis [35]. There are several symptoms
which can be predictive of endometriosis as severe dysmen-
orrhoea in infertile women, abdominopelvic pain, dysmen-
orrhoea, heavy menstrual bleeding, infertility, dyspareunia,
postcoital bleeding and/or previous diagnosis of ovarian cyst,
irritable bowel syndrome, or pelvic inflammatory disease
[36] and these symptoms and signs can help us to consider
the diagnosis of endometriosis when an umbilical nodule is
present. In order to diagnose this condition, CT, MRI, ultra-
sonography, and serum carbohydrate antigen 125 levels are
commonly used, but the results of these screening procedures
are inconclusive. Ultrasound is useful in defining whether a
mass is cystic or solid, but it has low specificity for diagnosing
endometriomas [3, 37]. The ultrasound characteristics of
endometriomas, in premenopausal women, include ground
glass echogenicity, one to four compartments, and no pap-
illary structures with detectable blood flow [38]. In women
with signs and symptoms of rectal endometriosis, transvagi-
nal sonography is useful for detecting or ruling out rectal
endometriosis [39], but as it is a procedure very dependent
on the operator, it is not recommended for diagnosis of rectal
endometriosis, except if it is executed by clinicians highly
experienced in transvaginal ultrasound [35]. In umbilical
endometriosis, CT scan generally demonstrates a solid well-
circumscribed mass and may be useful in showing the extent
of the disease [3].MRI is useful to define the size and locations
of lesions and to exclude the possibility of intraabdominal
extension [12, 40]. MRI usefulness to diagnose peritoneal
endometriosis is not well established [41]. The suspicion
of the diagnosis of umbilical endometriosis is based on
the clinical presentation, but the definitive diagnosis should
always be confirmed by histological examination following
biopsy or resection [12].The histological features required for
the diagnosis of endometriosis are the concomitant presence
of two of the three following characteristics: endometrial-like
glands, endometrial stroma, or hemosiderin pigment [3].
The treatment of choice for umbilical endometriosis is the
excision en-bloc of the lesions with wide margins with a sub-
sequent course of medication effective in inducing endome-
trial atrophy [42, 43]. The laparoscopic pelvic observation
should be performed as 13%–15% of umbilical endometriosis
cases are accompanied by pelvic endometriosis [42]. Drugs
such as gonadotropin-releasing hormone agonist (GnRH)
or contraceptive pill alone is insufficient and should not be
done before surgery, but this medication can be helpful for
the relief of symptoms resulting from pelvic endometriosis.
Therefore, there is several hormonal therapies used for
the relief of pain associated with endometriosis: hormonal
contraceptives, progestogens and antiprogestogens, GnRH
agonists and antagonists, and aromatase inhibitors are at
present in clinical use. All hormonal drugs used to treat pain
associated with endometriosis are effective in controlling the
symptoms and there is no clear evidence that a treatment is
superior to another; thus treatment should be individualized,
considering patient preferences, side effects, efficacy, costs,
and availability [35]. Recommendations to patients after
laparoscopic surgery are based on the operative findings and
results of surgery. The main goal of postoperative medical
treatment is suppressing ovarian activity resulting in atrophy
of endometriotic lesions.The success of this therapy is related
to the total excision of the endometriotic lesions so that
the recurrence of the disease could be minimised and the
absence of pain maintained [44]. Recurrence is rare after
complete excision of the lesion [2, 12, 20]. Goldberg and
Bedaiwy report a case of recurrence of secondary umbilical
endometriosis 7 months following excision of the lesion and
this was successfully treated with silver nitrate cautery [45].
The recurrent lesions can result from incomplete excision of
previous lesions or from de novo cells. Identifying risk factors
for recurrence may permit the recognition of subgroups
at risk for disease control [44]. Several risk factors have
been proposed, but there is controversy about which one
is more predictive for recurrence. Risk factors like history
of endometriosis surgery, bilateral pelvic involvement of
endometriotic lesions, left-sided endometrioma, tenderness,
nodularity at cul-de-sac, postoperative high revised Amer-
ican Fertility Society (rAFS) scores, and younger age were
considered [44]. Ghezzi et al. reported that the probability of
endometriosis recurrence is lower when it is located only on
the right side of the pelvis and the time to achieve pregnancy
after surgery, in couples who tried to conceive, seems to
be shorter when the endometriosis is localized in the right
hemipelvis [46].Malignant transformation has been reported
in 0.3–1% of cutaneous endometriosis. The most frequent
histological subtypes are endometrioid carcinoma, clear cell
carcinoma, adenosarcoma, and serous adenocarcinoma [2,
12, 20]. There is a reported case of clear cell adenocarcinoma
arising fromumbilical endometriosis in a 60-year-oldwoman
who underwent hysterectomy for a uterine myoma at the age
of 38 andwhodenied cyclic bleeding at the site of an umbilical
cutaneous nodule correlating with menses until the age of
48 [47]. There are no proven favorable results of hormonal
therapy within 6 months after surgery, if it is prescribed
with the exclusive purpose of improving the outcome of
surgery for pain [48]; nonetheless this hormonal therapy
could be prescribed for other indications, as contraception or
secondary prevention.
Our case describes a woman in her reproductive age
with secondary umbilical endometriosis, with cyclical pain
and umbilical blood discharge during menstruation, with
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previous diagnosis of endometriosis in the appendix and
a concomitant endometrioma in the right ovary. Initially,
before the patient has been referred to the gynecology depart-
ment, umbilical endometriosis was misdiagnosed and was
considered a dermoid cyst. After laparoscopy, our patient was
followed up with a standard gynaecological examination, the
assessment of painful symptoms, and a TV-US scan that were
performed at 1, 3, 6, and 12 months, and this will be repeated
subsequently on a yearly basis. The differential diagnosis
of an umbilical nodule includes inflammatory disorders
(abscess, folliculitis, and omphalitis), other benign lesions
(lipoma, haemangioma, inclusion cyst, urachal anomalies,
and pyogenic granuloma), umbilical hernia, and malignant
tumors (adenocarcinoma, sarcoma, melanoma, metastatic
visceral carcinoma—Sister Mary Joseph nodule) [13, 30].
This case highlights the importance of medical history
compared to those of complementary diagnostic tests which
are sometimes inconclusive. Surgeons should always consider
umbilical endometriosis in their diagnostic approach when
confronted with umbilical nodules. The evidence of the
results of diagnosis and the different options to treat extra-
genital endometriosis is limited. Clinicians may consider
surgical removal of symptomatic extragenital endometriosis,
and when this is not possible, medical treatment should be
considered to relieve symptoms. More studies are necessary
to conclude about the best method of diagnosis of umbilical
endometriosis and themost appropriate recommendations to
treatment and follow-upwhich include the bestmedication to
prevent the recurrence of the disease.
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